A Quick Look at Today's Ratings for Encompass Health(EHC.US), With a Forecast Between $130 to $135
Encompass Health Is Maintained at Buy by UBS
Encompass Health Is Maintained at Outperform by RBC Capital
Encompass Health Analyst Ratings
Encompass Health Price Target Raised to $135.00/Share From $116.00 by Truist Securities
Analysts' Top Healthcare Picks: Encompass Health (EHC), Evaxion Biotech (EVAX)
Deutsche Bank Raises Price Target on Encompass Health to $130 From $118, Keeps Buy Rating
William Blair Maintains Encompass Health(EHC.US) With Buy Rating
BofA Securities Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $128
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating
Encompass Health Is Maintained at Overweight by Keybanc
Keybanc Maintains Overweight on Encompass Health, Raises Price Target to $122
A Quick Look at Today's Ratings for Encompass Health(EHC.US), With a Forecast Between $120 to $129
Encompass Health Analyst Ratings
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $129
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Encompass Health (EHC) and Integer Holdings (ITGR)
Barclays Maintains Encompass Health(EHC.US) With Buy Rating, Maintains Target Price $118
William Blair Initiates Encompass Health(EHC.US) With Buy Rating
William Blair Sticks to Its Buy Rating for Encompass Health (EHC)
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating, Announces Target Price $116